Arsonoliposomes for drug delivery

Journal of Drug Delivery Science and Technology

Volumn 17, Issue 6, 2007, Pages 377-388

  Antimisiaris, S G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Anti cancer; Anti parasitic; Arsenic; Arsenolipid; Arsonolipid; Arsonoliposomes; Biodistribution; Drug delivery; Liposomes; Pharmacokinetics

Indexed keywords

1,2 DISTEAROYL GLYCERO 3 PHOSPHOCHOLINE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ARSENIC; ARSENIC ACID; ARSONOLIPID; ARSONOLIPOSOME; CALCEIN; CHOLESTEROL; DIVALENT CATION; DOXORUBICIN; EDETIC ACID; GLUTATHIONE; LIPID; LIPOSOME; MACROGOL; MACROGOL 2000; MILTEFOSINE; NANOCARRIER; PENTAMIDINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; CANCER CELL; CELL INTERACTION; CELL VIABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON MICROSCOPY; FOLLOW UP; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LIPID COMPOSITION; MORPHOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PROSTATE CANCER; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SURFACE CHARGE; TRYPANOSOMIASIS; UNSPECIFIED SIDE EFFECT; VISCERAL LEISHMANIASIS;

EID: 37549040907     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(07)50077-8     Document Type: Review

References (72)

1. Webb, M.S., Sarris, A.H., Cabanillas, F., Mayer, L.D., Bally, M.B., Burge, C., Cullis, P.R. - Clinical and preclinical pharmacology of liposomal vincristine. - J Lipos. Research, 10, 501-512, 2000.
2. Peer, D., Margalit, R. - Loading mitomycin c inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. - Int. J. Cancer, 108, 780-789, 2004.
3. Hao, Y.-L., Deng, Y.-J., Chen, Y., Wang, K.-Z., Hao, A.-J., Zhang, Y. - In vitro cytotoxicity, in vivo biodistribution and anti-tumour effect of pegylated liposomal topotecan. - J. Pharm. Pharmac, 57, 1279-1287, 2005.
4. Sharma, G., Anabousi, S., Ehrhardt, C., Ravi Kumar, M.N.V. - Liposomes as targeted drug delivery systems in the treatment of breast cancer. - J. Drug Targeting, 14, 301-310, 2006.
5. Allen, T.M., Martin, F.J. - Advantages of liposomal delivery systems for anthracyclines. - Semin. in Oncol., 31 (Suppl. 13), 5-15, 2004.
6. Martini, A., Ciocca, C. - Drug delivery systems for cancer drugs. - Exp. Opinion on Ther. Patents, 13, 1801-1807, 2003.
7. Kohno, S., Tomono, K., Maesaki, S. - Drug delivery systems for infection: liposome-incorporating antimicrobial drugs. - J Inf. Chemother., 4, 159-173, 1998.
8. Sörgel, F., Landersdorfer, C., Holzgrabe, U. - The great achievements and inventions of Paul Ehrlich | [Welche berufsbezeichnung wird Ehrlichs wirken gerecht?]. - Chemotherapie Journal, 13, 157-165, 2004.
9. Riethmiller, S. - From atoxyl to salvarsan: searching for the magic bullet. - Chemotherapy, 51, 234-242, 2005.
10. Drews, J. - Paul Ehrlich: Magister Mundi. - Nature Reviews Drug Discovery, 3, 797-801, 2004.
11. Paramore, A., Frantz, S. - Bortezomib. market analysis. - Nature Reviews Drug Discovery, 2, 611-612, 2003.
12. Blagosklonny, M.V. - Analysis of FDA approved anticancer drugs reveals the future of cancer therapy. - Cell Cycle, 3, 1035-1042, 2004.
13. Zhu, J., Chen, Z., Lallemand-Breitenbach, V., De Thé, H. - How acute promyelocyte leukaemia revived arsenic. - Nature Reviews Cancer, 2, 705-713, 2002.
14. Sanz, M.A., Lo-Coco, F. - Arsenic trioxide: its use in the treatment of acute promyelocyte leukemia. - American Journal of Cancer, 5, 183-191, 2006.
15. Kallinteri, P., Fatouros, D., Klepetsanis, P., Antimisiaris, S. G. - Arsenic trioxide liposomes, encapsulation efficiency and in vitro stability. - J. Lipos. Res., 14, 27-38 2004.
16. Chen, H., Macdonald, R.C., Li, S., Krett, N.L., Rosen, S.T., O'Halloran, T.V. - Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release. - JACS, 128, 13348-13349, 2006.
17. Dembitsky, V.M., Levitsky, D.O. - Arsenolipids. - Progress in Lipid Res., 43, 403-448, 2004
18. Kohlmeyer, U., Jakubik, S., Kuballa, J., Jantzen, E. - Determination of arsenic species in fish oil after acid digestion. - Microchim Acta, 151, 249-255, 2005
19. Tsivgoulis, G.M., Sotiropoulos, D.N., Ioannou, P.V. - Rac-1,2-diacylo-xypropyl-3-arsonic acids: arsonolipid analogues of phosphonolipids. - Phosphorous, Sulfur, and Silicon, 63, 329-334, 1991.
20. Serves, S.V., Sotiropoulos, D.N., Ioannou, P.V., Jain, M.K. - One pot synthesis of arsonolipid via thioarsenite precursors. - Phosphorous, Sulfur, and Silicon, 81, 181-190, 1993.
21. Kigawa, J., Minagawa, Y., Kanamori, Y., Itamochi, H., Cheng, X., Okada, M., Oishi, T., Terakawa, N. - Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. - Cancer, 82, 697-702, 1998.
22. Serves, S.V., Sotiropoulos, D.N., Ioannou, P.V., Jain M.K. - Synthesis of (r)- and (s)-1,2-diacyloxypropyl-3-arsonic acids: optically active arsonolipids. - Phosphorous, Sulfur, and Silicon, 71, 99-105, 1992.
23. Gortzi, O., Papadimitriou, E., Kontoyannis, C., Antimisiaris, S.G., Ioannou, P.V. - Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture. - Pharm. Research, 19, 79-86, 2002.
24. Gortzi, O., Papadimitriou, E., Antimisiaris, S.G., Ioannou, P.V. - Cytotoxicity of arsonolipid containing liposomes towards cancer and normal cells in culture: effect of arsonolipid acyl chain length. - Eur. J. Pharm. Sciences, 18, 175-183, 2003.
25. Antimisiaris S.G., Ioannou, P.V., Loiseau, P.M. - In vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in vivo distribution. - J. Pharm Pharmacol, 55; 647-652, 2003.
26. Zagana, P., Klepetsanis, P., Ioannou, P.V., Loiseau, P.M., Antimisiaris, S.G. - Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition. Biomed. & Pharmac., 61, 499-504, 2007.
27. Fatouros D., Ioannou, P.V. Antimisiaris, S.G. - Novel nanosized arsenic containing vesicles for drug delivery: arsonoliposomes. - J. Nanosc & Nanotech, 6, 2618-2687, 2006.
28. Fatouros, D., Gortzi, O., Klepetsanis, P., Antimisiaris, S.G., Stuart, M.C., Brisson, A., Ioannou, P. V. - Preparation and properties of arsonolipid containing liposomes. - Chem. Phys. Lipids, 109, 75-89, 2001.
29. Piperoudi, S., Ioannou, P.V., Frederik, P., Antimisiaris, S.G. - Arsonoliposomes: effect of lipid composition on their stability. - J Lipos. Res., 15, 187-197, 2005.
30. Piperoudi, S., Fatouros, D., Ioannou, P.V., Frederik, P., Antimisiaris, S.G. - Incorporation of peg-lipids in arsonoliposomes can produce highly stable arsenic-containing vesicles of specific lipid composition. - Chem. Phys. Lipids, 139, 96-106, 2006
31. Talsma, H., Van Steenbergen, M., Borchert, J., Crommelin, D. - A novel technique for the one-step preparationof liposomes and non-ionic surfactant vesicles in a continuous gas stream: The 'Bubble Method'. - J. Pharm. Sci., 83, 276-280, 1994.
32. Koutsopoulos, S., Fatouros, D.G., Ioannou, P.V., Antimisiaris, S.G. - Thermal behaviour of non-sonicated arsonolipid dispersions. - Biophys. Chem., 121, 150-54, 2006
33. Gregoriadis, G., Ryman, B.E. - Fate of protein-containing liposomes injected into rats. an approach to the treatment of storage diseases. - Eur. J. Biochem., 24, 485, 1972.
34. Gregoriadis, G., Ryman, B.E. - Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. - Biochem.. J., 129, 123-133, 1972.
35. Allen, T.M. - The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. - Adv. Drug Del. Rev., 13, 285-309, 1994.
36. Chapman D. (Ed.). - Introduction to Lipids. - McGraw-Hill, London, 1969.
37. New R.C.C. (Ed.). - Liposomes: A Practical Approach. - IRL Press, Oxford, 1990.
38. Fatouros, D.G., Piperoudi, S., Gortzi, O., Ioannou, P.V., Antimisiaris, S.G. - Physical stability of sonicated arsonoliposomes: effect of calcium ions. - J. Pharm. Sci.-US, 94, 46-55, 2005
39. Kenworthy, A.K., Hristova, K., Needham, D., Mcintosh, T.J. - Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attacged poly(ethylene glycol). - Biophys. J., 68, 1921-1936, 1995.
40. Belsito, S., Bartucci, R., Sportelli, L. - Lipid chain length effect on the phase behaviour of PCS/PEG:2000-PES mixtures. a spin label electron spin resonance and spectrophotometric study. - Biophys. Chem., 93, 11-22, 2001.
41. Garbuzenko, O., Barenholz, Y., Priev, A. - Effect of grafted peg on liposome size and on compressibility and packing of lipid bilayer. - Chem. Phys. Lipids, 135, 117-129, 2005.
42. Strijkers, G.J., Mulder, W.J.M., Van Heeswijk, R.B., Frederik, P.M., Bomans, P., Magusin, P.C.M.M., Nicolay, K. - Magnetic resonance. - Materials in Phys. Biol. & Medicine, 18, 186-192, 2005.
43. Fatouros, D.G., Klepetsanis, P., Ioannou, P.V., Antimisiaris, S.G. - The effect of ph on the electrophoretic behaviour of a new class of liposomes: Arsonoliposomes. - Int. J. Pharm., 288, 151-156, 2005.
44. Doak G.O., Freedman L.D. (Eds.). - Organometallic Compounds of Arsenic, Antimony and Bismuth. - Wiley, New York, 1970.
45. Trauble, H., Eibl, H. - Electrostatic effects on lipid phase transitions: membrane structure and ionic environment. - Proc. Natl. Acad. Sci. USA, 71, 214-219, 1974.
46. Eibl, H., Phospholipids as functional constituents of biomembranes. - Angew. Chem. Int. Ed. Engl, 23, 257-71, 1984.
47. Senior, J.H., Gregoriadis, G. - Is half-life of circulating liposomes determined by changes in their permeability? - FEBS Letters, 145, 109-114, 1982.
48. Gregoriadis G. (Ed.). - Liposome Technology. - CRC Press, Boca Raton, FL, 1993.
49. Batzri, S., Korn, E.D. - Single bilayer liposomes prepared without sonication. - Biochim. Biophys. Acta, 298, 1015-1019, 1973.
50. Senior, J. H. - Fate and behavior of liposomes in vivo: a review of controlling factors. - Crit. Rev. Ther. Drug Carrier Syst., 3, 123-193, 1987.
51. Schneider, T., Sachse, A., Leike, J., Robling, G., Schmidtgen, M., Drechsler M., Brandl, M. - Surface modification of continuously extruded contrast-carrying liposomes: effect on their physical properties. - Int. J. Pharm., 132, 9-21, 1996.
52. Wilschut, J., Duzgunes, N., Hong, K., Hoekstra, D., Papahadjopoulos, D. - Retention of aqueous contents during divalent cation-induced fusion of phospholipid vesicles. - Biophys. Biochim. Acta, 734, 309-318, 1983.
53. Nagayasu, A., Uchiyama, K., Kiwada, H. - The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. - Adv. Drug Deliv. Rev., 40, 75-87, 1999.
54. Bentz, J., Nir, S. - Aggregation of colloidal particles modeled as a dynamical process. - Proc. Natl. Acad. Sci. USA, 78, 1634-1637, 1981.
55. Haikou, M., Zagana, P., Ioannou P.V., Antimisiaris S.G. - Arsonoliposome interaction with thiols. effect of pegylation and arsonolipid content on their integrity during incubation in the presence of glutathione. - J. Nanosc & Nanotech., 6, 2974-2978, 2006.
56. Andresen, T.L., Jensen, S.S, Jorgensen, K. - Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumour specific drug release. - Progress In Lipid Research, 44, 68-97, 2005.
57. Antimisiaris, S.G., Klepetsanis, P., Zachariou, V., Giannopoulou, E., Ioannou, P.V. - In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice. - Int. J. Pharm., 289, 151-158, 2005.
58. Parsegian, V.A., Rand, R.P. - Membrane interaction and deformation. - Ann. N. Y. Acad. Sci., 416, 1-12, 1983.
59. Kachar, B., Fuller, N., Rand, R.P. - Morphological responses to calcium-induced interaction of phosphatidylserine-containing vesicles. - Biophys. J., 50, 779-788, 1986.
60. Devalla, S., Feldmann, J. - Determination of lipid-soluble arsenic species in seaweed-eating sheep from Orkney. - Applied Organometallic Chemistry, 17, 906-912, 2003.
61. Hughes, M.F., Kenyon, E.M., Edwards, B.C., Mitchell, C.T., Thomas, D.J. - Strain-dependent disposition of inorganic arsenic in the mouse. - Toxicology, 137, 95-108, 1999.
62. Zagana, P., Haikou, M., Klepetsanis, P., Giannopoulou, E., Ioannou, P.V., Antimisiaris S.G. - In vivo distribution of arsonoliposomes: effect of vesicle lipid composition. - Int. J. Pharm., In press, 2007.
63. Sadzuka, Y., Nakai, S., Miyagishima, A., Nozawa, Y., Hirota, S. - Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing Adriamycin. - Cancer Lett., 111, 77-86. 1997.
64. Sadzuka, Y., Hirota, S., Sonobe, T. - Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination. - Toxicol. Lett., 116, 51-59, 2000.
65. Zagana, P., Haikou, M., Giannopoulou, E., Ioannou, P.V., Antimisiaris, S.G. - Effect of lipid composition and pegylation on the interaction of arsonoliposomes with thiols and their in vitro cytotoxicity towards PC3 cells. - Review of Clin. Pharmacol. Pharmacokin., 20, 352-354, 2006.
66. Papadimitriou, E,. Antimisiaris, S.G. - Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro. - J Drug Target., 8, 335-351, 2000.
67. Daleke, D. L., Hong, K., Papahadjopoulos, D. - Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. - Biochim. Biophys. Acta, 1024, 352-366, 1990.
68. Balaña-Fouce, R., Reguera, R.M., Cubría, J.C., Ordóñez, D. - The pharmacology of leishmaniasis. - Gen. Pharrmacol., 30, 435-443. 1998.
69. Alving, C.R., Steck, E.A., Chapman, W.L., Waits, V.B., Hendricks, L.D., Swartz, G.M., Hanson, W.L. - Liposomes in Leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. - Life Sci., 26, 2231-2238, 1980.
70. Brodgen, R.N., Heel, R.C., Speight, T.M., Avery, G.S. - Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. - Drugs, 16, 387-417, 1978.
71. Denise, H., Barrett, M.P. - Uptake and mode of action of drugs used against sleeping sickness. - Biochem. Pharmacol., 61, 1-5, 2001.
72. Date, A.A., Joshi, M.D., Patravale, V.B. - Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. - Adv. Drug Deliv. Rev., 59, 505-521, 2007.